AMA Highlights Concerns Over Medicare Advantage Prior Authorization Denials and AI Impact on Older Americans in National Advocacy Update

The American Medical Association's (AMA) National Advocacy Update for July 10, 2026, draws attention to several key health policy developments. Notably, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) released two reports detailing significant issues with Medicare Advantage (MA) plans' prior authorization denials for post-acute care. These reports reinforce long-standing AMA concerns about inappropriate MA prior authorization denials, particularly for vulnerable patients, and highlight the need for increased oversight. Additionally, a bipartisan Senate bill, the 'Aging with Artificial Intelligence Act,' was introduced to direct federal research into how AI tools are impacting older Americans, a legislative effort supported by AMA expertise.

Context

The reports from the HHS OIG reveal systemic problems with Medicare Advantage plans denying prior authorizations, a concern the AMA has raised for years. These denials can delay or prevent essential medical services for patients recovering from serious health issues. The bipartisan Senate bill aims to address the intersection of aging and technology, reflecting a broader societal concern about how AI may affect the health and well-being of older adults.

Why it matters

The AMA's update highlights critical issues surrounding Medicare Advantage prior authorization denials, which can affect access to necessary post-acute care for vulnerable patients. This situation underscores the need for improved oversight to protect patients' rights and ensure they receive timely care. Additionally, the introduction of the 'Aging with Artificial Intelligence Act' signals a growing recognition of the need to understand the implications of AI on older populations.

Implications

If Medicare Advantage prior authorization practices are not reformed, vulnerable patients may continue to face barriers to necessary care, potentially worsening health outcomes. The findings could lead to increased scrutiny of insurance practices and push for legislative changes. Furthermore, research into AI's impact on older Americans could inform future policies and technology development, potentially improving the quality of care for this demographic.

What to watch

In the near term, stakeholders will monitor the response from HHS regarding the OIG reports and any potential policy changes to improve oversight of Medicare Advantage plans. The progress of the 'Aging with Artificial Intelligence Act' in Congress will also be closely watched, as it could lead to significant federal research initiatives. Advocacy groups may ramp up efforts to address the issues raised in the AMA's update.